Health Care: Drugs

NewLink Genetics Corp (NLNK: NASDAQ)

$11.105 0.395 | 3.69%
12/05/16 - 10:40 AM ET
Company Profile
Price and Volume
Recent Price 10.71
52 Week High 37.65
52 Week Low 9.23
Avg. Daily Vol. (Mil) 0.31
Beta (3 year) 1.42
Share Related Items
Mkt Cap (Mil) 312.03
Shares Out (Mil) 29.13
Float (Mil) 21.35
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.10
Current Ratio 4.40
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 10.16
Price/Book 2.26
Price/Cash Flow -3.60
Per Share Data
Earnings -3.23
Sales 1.05
Book Value 4.75
Cash Flow -2.99
Business Summary
NewLink Genetics Corp is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing immunotherapeutic products to improve treatment options for patients with cancer.
General Information
2503 South Loop Drive
Suite 5100
Ames, IA 50010
www.newlinkgenetics.com
Industry : Drugs
Sector: Health Care
Employees: 210
CEO: Mr. Charles J. Link, Jr
Short Interest
Current Month (Mil) 2.16
Previous Month (Mil) 2.16
Short Interest Ratio (Days) 8.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -50.00
Return on Investments -67.30
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with NLNK

Latest NLNK Headlines from TheStreet

More Financial News for NLNK

Press Releases for NLNK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter